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Aloe emodin (1, 8-dihydroxy-3-(hydroxymethyl)-anthraquinone), a natural anthraquinone, is
reported to have antiproliferative activity in various cancer cell lines. In this study we made
an effort to analyze the molecular mechanisms involved in the growth inhibitory activity of
this hydroxy anthraquinone in colon cancer cell line, WiDr. In our observation aloe emodin
inhibited cell proliferation by arresting cell cycle at G2/M phase through induction of p21 and
downregulation of cyclin B1. It also modulated the expression of MAPKs by inhibiting
phosphorylation of ERK1/2 and activating phospho JNK1/2 and phosphor p38. Aloe emodin
appreciably induced cell death specifically through apoptotic pathway, activating caspases
9/6 and by inactivating PARP. Aloe emodin induced apoptotic execution in WiDr cell was
found to be solely dependent on the caspase- 6 than caspase- 3 or 7. Apart from these
apoptosis specific molecular changes, morphological observations also revealed the
apoptotic potential of aloe emodin by loss of plasma membrane and mitochondrial
membrane integrity, DNA fragmentation etc. Our results also show that at a relatively non
toxic level of aloe emodin suppressed the phorbol-12-myristyl-13-acetate (PMA) induced
migration and invasion. On analysis of the molecules involved in the migration and invasion,
we found mRNA expression and promoter function of MMP-2, 9, Cyclin B1 and RhoB were
downregulated. It is also found that PMA induced gelatinolytic activity of MMP-2/9 and
protein expression of RhoB was downregulated on treatement with aloe emodin. We have
also analyzed the involvement of specific transcription factors in aloe emodin mediated down
regulation of MMP-2/9. Among the two transcription factors analysed, NF-κB and AP1, NF-
κB was having significant role in aloe emodin induced pharmacological changes in WiDr
cells. Binding of NF-κB to specific DNA sequence was inhibited by the treatment of aloe
emodin and it also found to reduce the translocation of p50, one of the subunits of NF-κB, in
to the nucleus. Aloe emodin also inhibited VEGF expression and Human Umbilical Vein
Endothelial cells (HUVECs) migration/invasion and in vitro tube formation.

